About: Holger Schünemann

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Holger Schünemann Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

German cell biologist and epidemiologist based in Canada

Attributes	Values
rdf:type	Item
field of work	wds:Q28039195-4BC2832E-A2C7-4146-8782-2C983524EB14
field of work	systematic review
description	গবেষক (bn) հետազոտող (hy) hulumtues (sq) ഗവേഷകന്‍ (ml) onderzoeker (nl) German cell biologist and epidemiologist based in Canada (en)
rdfs:label	Holger J Schünemann (nl) Holger Schünemann (en) Holger Schünemann (es) Holger Schünemann (sl) Holger Schünemann (ast)
skos:prefLabel	Holger J Schünemann (nl) Holger Schünemann (en) Holger Schünemann (es) Holger Schünemann (sl) Holger Schünemann (ast)
name	Holger J Schünemann (nl) Holger Schünemann (en) Holger Schünemann (es) Holger Schünemann (sl) Holger Schünemann (ast)
given name	wds:Q28039195-2CD101B1-526E-4C0E-8AD8-70198F22183A
given name	Holger
instance of	wds:Q28039195-956D049B-679B-4BE3-BF1B-384BE5469E65
instance of	Homo sapiens
skos:altLabel	Holger J Schünemann (en) Holger Schunemann (en)
occupation	wds:Q28039195-3639BF06-BCF0-4CC2-996A-2F6ACB1BA8A8 wds:Q28039195-57C881C5-9287-4B05-B666-67D711D3C4D3
sex or gender	wds:Q28039195-D879C42E-6B50-478E-9C55-209EC3B24615
on focus list of Wikimedia project	wds:Q28039195-8BF525B0-D813-4B11-A36B-EBBCC22FA00A
family name	wds:Q28039195-F1F038B8-F8FE-4B68-AEDB-4C5BC99F02B6
occupation	epidemiologist cell biologist
sex or gender	male
on focus list of Wikimedia project	WikiProject COVID-19
family name	Schünemann
ORCID iD	wds:Q28039195-A5347913-98FA-4AED-84C2-9E715D6885AA
Dimensions author ID	wds:Q28039195-1B271470-06C2-4E42-88A0-760DD9888429
ORCID iD	https://orcid.org/0000-0003-3211-8479
ORCID iD	0000-0003-3211-8479
Dimensions author ID	01034250247.19
is owl:sameAs of	Holger Schünemann
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28039195
is author of	Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies Patient-reported outcomes in meta-analyses--Part 1: assessing risk of bias and combining outcomes The impact of illness in patients with moderate to severe gastro-esophageal reflux disease Response to paper by Lang A, Edwards N, and Fleiszer A. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health GRADE system: new paradigm Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Using alternative statistical formats for presenting risks and risk reductions Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials Validity of composite end points in clinical trials GRADE: assessing the quality of evidence for diagnostic recommendations An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. A comparison of the original chronic respiratory questionnaire with a standardized version. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Effects of water-pipe smoking on lung function: a systematic review and meta-analysis High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS Global differences in lung function by region (PURE): an international, community-based prospective study Improving the use of research evidence in guideline development: 6. Determining which outcomes are important Improving the use of research evidence in guideline development: 1. Guidelines for guidelines Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations Improving the use of research evidence in guideline development: 7. Deciding what evidence to include Improving the use of research evidence in guideline development: 14. Reporting guidelines Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence Improving the use of research evidence in guideline development: 2. Priority setting Improving the use of research evidence in guideline development: 16. Evaluation Improving the use of research evidence in guideline development: 5. Group processes Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation Grading quality of evidence and strength of recommendations Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Combining scores from different patient reported outcome measures in meta-analyses: when is it justified? Assessing and presenting summaries of evidence in Cochrane Reviews How to use an article reporting a multiple treatment comparison meta-analysis. The GRADE approach and Bradford Hill's criteria for causation An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. Randomized trials stopped early for benefit: a systematic review What is "quality of evidence" and why is it important to clinicians? Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units GRADE guidelines: 9. Rating up the quality of evidence GRADE guidelines: 8. Rating the quality of evidence--indirectness GRADE guidelines: 5. Rating the quality of evidence--publication bias GRADE guidelines: 7. Rating the quality of evidence--inconsistency GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software